Ihlaseh SM, et al. Manuscrito
30
11. Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, et al. STEAP: a
prostate-specific cell-surface antigen highly expressed in human prostate tumors.
Proc Natl Acad Sci U S A. 1999; 96: 14523-8.
12. Porkka KP, Helenius MA, Visakorpi T. Cloning and characterization of a novel six-
transmembrane protein STEAP2, expressed in normal and malignant prostate. Lab
Invest. 2002; 82(11):1573-82.
13. Yang D, Holt GE, Velders MP, Kwon ED, Kast M. Murne six-transmembrane
epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific
membrane antigen: prostate-specific cell-surface antigens hightly expressed in
prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res.
2001; 61: 5857-60.
14. Challita-Eid PM, Morrison K, Etessami S, Morrison ZAKJ, Perez-Villar JJ, Raitano
AB, et al. Monoclonal antibodies to six-transmembrane epithelial antigen of the
prostate-1 inhibit intercellular communication in vivo and growth of human tumor
xenografts in vivo. Cancer Res. 2007; 67: 5798-805.
15. Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, Saatcioglu F. Molecular
cloning and characterization of STAMP1, a highly prostate-specific six
transmembrane protein that is overexpressed in prostate Cancer. REVISTA 2002;
277: 36689-96.
16. Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are
metalloreductases. Blood. 2006; 108: 1388-94.
17. Sanches-Pulido L, Rojas AM, Valencia A, Martinez-A C, Andrade MA. ACRATA:
a novel electron transfer domain associated to apoptosis and câncer. BMC Cancer.
2004; 4:98.
18. Strohmeyer DM, Berger AP, Moore DH 2nd, Bartsch G, Klocker H, Carroll PR,
Loening SA, Jensen RH. Genetic aberrations in prostate carcinoma detected by
comparative genomic hybridization and microsatellite analysis: association with
progression and angiogenesis. Prostate. 2004; 59(1): 43-58.
19. Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P, Ferrari M, Hernandez-
Boussard T, Brooks JD, Pollack JR. Genomic profiling reveals alternative genetic
pathways of prostate tumorigenesis. Cancer Res. 2007; 67(18): 8504-10.
20. Rodeberg DA, Nuss RA, Elsawa SF, Celis E. Recognition of six-transmembrane
epithelial antigen of the prostate – expressing tumor cells by peptide antigen –
induced cytotoxic T lymphocytes. Clin Cancer Res. 2005; 11: 4545-52.